PIII vs. IMAQ, FICV, BLEU, GACQ, CBRG, INNV, WGS, TALK, DCGO, and SHCR
Should you be buying P3 Health Partners stock or one of its competitors? The main competitors of P3 Health Partners include International Media Acquisition (IMAQ), Frontier Investment (FICV), bleuacacia (BLEU), Global Consumer Acquisition (GACQ), Chain Bridge I (CBRG), InnovAge (INNV), GeneDx (WGS), Talkspace (TALK), DocGo (DCGO), and Sharecare (SHCR).
International Media Acquisition (NASDAQ:IMAQ) and P3 Health Partners (NASDAQ:PIII) are both small-cap consumer discretionary companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, community ranking, media sentiment, analyst recommendations, risk, dividends and valuation.
25.9% of International Media Acquisition shares are owned by institutional investors. Comparatively, 7.8% of P3 Health Partners shares are owned by institutional investors. 83.7% of International Media Acquisition shares are owned by insiders. Comparatively, 17.9% of P3 Health Partners shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
P3 Health Partners has a consensus target price of $4.75, suggesting a potential upside of 846.22%. Given International Media Acquisition's higher probable upside, analysts clearly believe P3 Health Partners is more favorable than International Media Acquisition.
P3 Health Partners received 4 more outperform votes than International Media Acquisition when rated by MarketBeat users.
International Media Acquisition has a net margin of 0.00% compared to International Media Acquisition's net margin of -4.97%. P3 Health Partners' return on equity of 0.00% beat International Media Acquisition's return on equity.
International Media Acquisition has higher earnings, but lower revenue than P3 Health Partners.
International Media Acquisition has a beta of 0.03, indicating that its stock price is 97% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.
In the previous week, P3 Health Partners had 1 more articles in the media than International Media Acquisition. MarketBeat recorded 3 mentions for P3 Health Partners and 2 mentions for International Media Acquisition. P3 Health Partners' average media sentiment score of 0.43 beat International Media Acquisition's score of 0.29 indicating that International Media Acquisition is being referred to more favorably in the media.
Summary
International Media Acquisition beats P3 Health Partners on 7 of the 13 factors compared between the two stocks.
Get P3 Health Partners News Delivered to You Automatically
Sign up to receive the latest news and ratings for PIII and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PIII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
P3 Health Partners Competitors List
Related Companies and Tools